ADMA Biologics, Inc. (ADMA)
9.52
-0.18
(-1.86%)
USD |
NASDAQ |
Sep 24, 16:00
9.67
+0.15
(+1.58%)
After-Hours: 06:32
ADMA Biologics Gross Profit (Annual) : 292.62M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 292.62M |
| December 31, 2024 | 219.16M |
| December 31, 2023 | 88.22M |
| December 31, 2022 | 34.55M |
| December 31, 2021 | 0.4579M |
| December 31, 2020 | -19.79M |
| December 31, 2019 | -11.00M |
| December 31, 2018 | -26.05M |
| Date | Value |
|---|---|
| December 31, 2017 | -14.14M |
| December 31, 2016 | -1.147M |
| December 31, 2015 | 2.866M |
| December 31, 2014 | -1.678M |
| December 31, 2013 | -1.374M |
| December 31, 2012 | 0.4491M |
| December 31, 2011 | -1.256M |
| December 31, 2010 | -4.070M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Erasca, Inc. | -3.107M |
| Vericel Corp. | 205.60M |
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Emergent BioSolutions, Inc. | 350.60M |
| Exelixis, Inc. | 2.236B |